Animal pharmacology and human psychopharmacology of 3-methoxy-4,5-methylenedioxyphenylisopropylamine (MMDA).
D000328:Adult; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004149:Dioxoles / Q000138:chemical synthesis / Q000494:pharmacology / Q000633:toxicity; D004285:Dogs; D004562:Electrocardiography; D004644:Emotions / Q000187:drug effects; D005260:Female; D006213:Hallucinogens / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D008738:Methyl Ethers / Q000138:chemical synthesis / Q000494:pharmacology / Q000633:toxicity; D051379:Mice; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D011437:Propylamines / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013997:Time Factors
D004149:Dioxoles; D006213:Hallucinogens; D008738:Methyl Ethers; D011437:Propylamines